ICNA President-Elect Elections 2024 are currently underway. All eligible voters (ICNA Full Members) have been emailed their unique voting credentials. All voting is done via the secure platform at https://icnapedia.org/pe2024. The voting site will remain open until 2400hrs GMT on 1 May 2024.
Dr. Evdokia Anagnostou, MD, is a senior clinician scientist, assistant director of the Bloorview Research Institute, co-lead of the Autism Research Centre , Canada Research chair in translational therapeutics in autism spectrum disorder (ASD) and the inaugural Dr. Stuart D. Sims Chair in Autism.
Dr. Anagnostou has dedicated her career to challenging the field of neurodevelopmental disorders (NDDs) to rethink diagnostic categories and focus on underlying biology rather than labels.
With the goal of precision medicine to ensure the best care and treatment for all children and families, Dr. Anagnostou has revolutionized traditional ways of thinking by redefining individual patterns of disease, which will lead to individualized treatments and more meaningful and healthier futures for all.